Conferences - Results from #11740

ICS 2013 - Abstract: Do we need to perform urodynamics studies before surgery for urinary incontinence in women? Cochrane systematic review and meta-analysis September 6, 2013

ICS 2013 - Abstract: Urodynamics before stress incontinence surgery -- a systematic review and meta-analysis September 6, 2013

ICS 2013 - Abstract: Urodynamics before stress incontinence surgery -- a systematic review and meta-analysis September 6, 2013

ICS 2013 - Podcast: Stephen R. Kraus, MD, FACS discusses highlights of the urodynamics sessions from the Annual Scientific Meeting of the International Continence Society September 6, 2013

ICS 2013 - Podcast: Stephen R. Kraus, MD, FACS discusses highlights of the urodynamics sessions from the Annual Scientific Meeting of the International Continence Society September 6, 2013

ICS 2013 - Abstract: A prospective randomised controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2 for painful bladder syndrome/interstitial cystitis September 4, 2013

ICS 2013 - Abstract: A prospective randomised controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2 for painful bladder syndrome/interstitial cystitis September 4, 2013

ICS 2013 - Podcast: Christopher K. Payne, MD, FACS discusses highlights of the bladder pain/interstitial cystitis sessions from the Annual Scientific Meeting of the International Continence Society September 4, 2013

ICS 2013 - Podcast: Christopher K. Payne, MD, FACS discusses highlights of the bladder pain/interstitial cystitis sessions from the Annual Scientific Meeting of the International Continence Society September 4, 2013

ICS 2013 - Abstract: Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) – efficacy and safety results from a randomised phase II study (SYMPHONY) September 3, 2013

ICS 2013 - Abstract: Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) – efficacy and safety results from a randomised phase II study (SYMPHONY) September 3, 2013

ICS 2013 - Abstract: The antidiuretic effect of fedovapagon can be effectively controlled by dose September 3, 2013

ICS 2013 - Abstract: The antidiuretic effect of fedovapagon can be effectively controlled by dose September 3, 2013

ICS 2013 - Abstract: Development of a short-form for evaluating the pathophysiologic mechanisms of nocturia September 3, 2013

ICS 2013 - Abstract: Development of a short-form for evaluating the pathophysiologic mechanisms of nocturia September 3, 2013

ICS 2013 - Podcast: Kari Tikkinen, MD, PhD discusses highlights of the overactive bladder and nocturia sessions from the Annual Scientific Meeting of the International Continence Society September 3, 2013

ICS 2013 - Podcast: Kari Tikkinen, MD, PhD discusses highlights of the overactive bladder and nocturia sessions from the Annual Scientific Meeting of the International Continence Society September 3, 2013

CUA 2013 - Session Highlights: Impact of enzalutamide on time to first skeletal related event (SRE) and pain in the phase III AFFIRM study June 27, 2013

CUA 2013 - Session Highlights: OnabotulinumtoxinA (onabotA) in patients with overactive bladder (OAB) and urinary incontinence (UI): Consistent effect over repeat treatment June 27, 2013

CUA 2013 - Slide Presentation: Current controversies in prostate cancer management June 25, 2013

Page 588 of 623